drugset / Trial / NCT01632709
Pathophysiology of Post Amputation Pain
Phase 4
Completed
16 enrolled
Shirley Ryan AbilityLab
Northwestern University · collabUnited States Department of Defense · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to see how Post Amputation Pain (PAP) affects the body and brain by using sensory testing (such as pinprick testing), taking pictures of your brain (using a functional magnetic resonance imaging (fMRI) machine) and biomedical interventions (such as an injection of pain medicine). All medicines and the fMRI machine used during this study are FDA approved. The investigators hope that by learning the causes of PAP, the investigators can help future amputees.
Timeline
- Start
- 2012-05
- Primary completion
- 2014-10
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bupivacaine | Other / unclassified | 0.25 % | Other |
| Comparator | Bupivacaine | Other / unclassified | 10 ml | Other |